For research use only. Not for therapeutic Use.
Larazotide acetate is a peptide-based drug under investigation for treating celiac disease. It works by modulating tight junctions in the intestinal lining, reducing gluten permeability and subsequent inflammation. This innovative approach aims to alleviate symptoms and improve the quality of life for celiac patients, offering a potential adjunct or alternative to a strict gluten-free diet.
Catalog Number | R029284 |
CAS Number | 881851-50-9 |
Synonyms | Glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-glycine Monoacetate; Glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-glycine Acetate (1:1) |
Molecular Formula | C₃₄H₅₉N₉O₁₂ |
Purity | ≥95% |
Target | Gap Junction Protein |
Storage | -20°C |